μ-crystallin Inhibitors
Chemical inhibitors of μ-crystallin can modulate the protein's activity through various mechanisms, primarily centered on the disruption of thyroid hormone binding. Phenylbutazone, Methimazole, and Propylthiouracil are chemicals that can directly or indirectly affect the function of μ-crystallin. Phenylbutazone achieves this inhibition by binding to the same sites on μ-crystallin that are typically reserved for thyroid hormones, resulting in competitive inhibition. Methimazole and Propylthiouracil, on the other hand, interfere with the synthesis of thyroid hormones by inhibiting thyroid peroxidase, an enzyme crucial for hormone production. With fewer thyroid hormones available to interact with μ-crystallin, the protein's activity is consequently reduced.
Additionally, flavonoids such as Quercetin, Kaempferol, and Myricetin, along with other compounds Genistein, can bind to the thyroid hormone receptor sites on μ-crystallin. This binding can prevent the interaction of thyroid hormones with μ-crystallin, which is essential for its metabolic regulatory functions. Bisphenol A also participates in this inhibition by binding to the thyroid hormone receptor, which would otherwise facilitate the activity of μ-crystallin through hormone interaction. Furthermore, Raloxifene and Tamoxifen, by acting on estrogen receptors, can influence the expression of enzymes involved in the synthesis of thyroid hormones, leading to reduced hormone levels that are necessary for the optimal functioning of μ-crystallin. Rivaroxaban, albeit through a different pathway, can alter thyroid hormone profiles by affecting liver enzymes responsible for hormone metabolism, indirectly leading to a decrease in the activation of μ-crystallin by the thyroid hormones.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Phenylbutazone | 50-33-9 | sc-204843 | 5 g | $32.00 | 1 | |
Phenylbutazone binds to thyroid hormone-binding sites on μ-crystallin, competitively inhibiting the binding of thyroid hormones which are crucial for μ-crystallin function in cellular metabolism regulation, thereby inhibiting the protein's activity. | ||||||
Methimazole | 60-56-0 | sc-205747 sc-205747A | 10 g 25 g | $70.00 $112.00 | 4 | |
Methimazole inhibits the peroxidase enzyme in the thyroid and could reduce the synthesis of thyroid hormones, which are known to bind μ-crystallin; less available thyroid hormone would result in reduced activation of μ-crystallin, thus functionally inhibiting it. | ||||||
6-Propyl-2-thiouracil | 51-52-5 | sc-214383 sc-214383A sc-214383B sc-214383C | 10 g 25 g 100 g 1 kg | $37.00 $56.00 $224.00 $1997.00 | ||
Propylthiouracil, similar to methimazole, inhibits thyroid peroxidase, leading to decreased thyroid hormone production. Since μ-crystallin is a thyroid hormone-binding protein, lower levels of thyroid hormone would result in reduced functional activity of μ-crystallin. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin can inhibit the binding of triiodothyronine (T3) to μ-crystallin by competitive inhibition at the hormone binding site, leading to functional inhibition of μ-crystallin's activity as a T3-binding protein. | ||||||
Kaempferol | 520-18-3 | sc-202679 sc-202679A sc-202679B | 25 mg 100 mg 1 g | $99.00 $216.00 $510.00 | 11 | |
Kaempferol interacts with the thyroid hormone receptor site on μ-crystallin, potentially inhibiting the binding of T3 and thus functionally inhibiting μ-crystallin's activity as a T3-binding protein. | ||||||
Myricetin | 529-44-2 | sc-203147 sc-203147A sc-203147B sc-203147C sc-203147D | 25 mg 100 mg 1 g 25 g 100 g | $97.00 $188.00 $260.00 $510.00 $1022.00 | 3 | |
Myricetin can occupy the T3 binding site on μ-crystallin, inhibiting the protein's ability to bind thyroid hormones which are essential for its function in metabolic regulation, resulting in functional inhibition. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, by binding to the thyroid hormone receptor, can inhibit the ability for thyroid hormones to interact with μ-crystallin, which is necessary for its function, thus resulting in the functional inhibition of μ-crystallin. | ||||||
Bisphenol A | 80-05-7 | sc-391751 sc-391751A | 100 mg 10 g | $300.00 $490.00 | 5 | |
Bisphenol A can bind to thyroid hormone receptor, potentially inhibiting the thyroid hormone interaction with μ-crystallin. Since the activity of μ-crystallin is dependent on thyroid hormone binding, this would result in functional inhibition of the protein. | ||||||
Raloxifene | 84449-90-1 | sc-476458 | 1 g | $802.00 | 3 | |
Raloxifene acts as a selective estrogen receptor modulator and can interfere with the hormone binding to its receptor. Since estrogen receptors can regulate the expression of enzymes involved in thyroid hormone synthesis, this could lead to decreased thyroid hormone levels, which are necessary for μ-crystallin activity, thus functionally inhibiting the protein. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Tamoxifen, another selective estrogen receptor modulator, has a similar effect to raloxifene, where it could lead to reduced thyroid hormone synthesis and availability. Lower thyroid hormone levels would inhibit μ-crystallin activity since it binds these hormones for its function. | ||||||